Celcuity Inc. - Common Stock (CELC)
Frequently Asked Questions About Celcuity Inc. - Common Stock (CELC)
Has Celcuity Inc. partnered with any other organizations?
Yes, Celcuity Inc. has formed partnerships and collaborations with various academic institutions, healthcare organizations, and other biopharmaceutical companies. These partnerships aim to enhance research and development efforts, leverage shared expertise, and accelerate the process of bringing innovative therapies to market.
How can investors stay updated on Celcuity Inc.'s progress?
Investors can stay updated on Celcuity Inc.'s progress by following company press releases, quarterly earnings calls, and filings with the Securities and Exchange Commission (SEC). The company also engages with shareholders through investor presentations and updates on their website to provide insights into recent developments and future plans.
How does Celcuity Inc. ensure the safety of its therapies?
Celcuity Inc. ensures the safety of its therapies through rigorous preclinical and clinical testing. This includes extensive laboratory research, ethical review processes, and phased clinical trials designed to carefully monitor the effects of their drugs on participants, identifying potential side effects and ensuring patient safety.
How does Celcuity Inc. handle patient access to its therapies?
Celcuity Inc. works to ensure patient access to its therapies through the establishment of patient support programs, engagement with healthcare providers, and collaboration with insurance companies. They aim to facilitate access to their treatments for eligible patients once they receive regulatory approval.
Is Celcuity Inc. publicly traded?
Yes, Celcuity Inc. is a publicly traded company. It went public in 2018 and operates under the ticker symbol CELC on the Nasdaq stock exchange, allowing investors to purchase shares and participate in the financial growth of the company.
What are Celcuity's future plans?
Celcuity Inc. aims to advance its pipeline of targeted therapies through continued clinical trials and seek regulatory approvals to bring their treatments to market. The company is also focused on expanding its research efforts to discover additional drug candidates and potential applications within oncology.
What are some of Celcuity's clinical trials?
Celcuity has conducted several clinical trials focusing on their lead drug candidates, including those aimed at treating patients with breast cancer and colorectal cancer. These trials are crucial for evaluating the efficacy and safety of their therapies, as well as to support the approval process by regulatory authorities.
What are the company's financial performance metrics?
Celcuity’s financial performance metrics include revenue from clinical trial grants, funding from investors, and any commercial sales if applicable. Investors can review their quarterly and annual financial statements to assess the company's performance, including revenue, expenses, and cash flow.
What challenges does Celcuity Inc. face in the biopharmaceutical industry?
Celcuity Inc. faces challenges typical of the biopharmaceutical industry, including navigating the complex regulatory landscape, managing the high costs associated with drug development, maintaining competitive advantage in a rapidly evolving market, and ensuring successful recruitment for clinical trials.
What does Celcuity Inc. do?
Celcuity Inc. is a biopharmaceutical company focused on developing and commercializing innovative and targeted therapies for cancer treatment. They utilize their proprietary Cellular Intelligence technology platform to discover and develop drugs that specifically target cancer cells, which helps in providing more personalized treatment options for patients.
What is Cellular Intelligence?
Cellular Intelligence is Celcuity Inc.'s proprietary technology platform that enables the discovery and development of cancer therapies by examining the signaling pathways in cancer cells. This innovative approach allows the identification of specific drug targets and aids in the development of therapies that can selectively destroy cancer cells.
What is the mission of Celcuity Inc.?
The mission of Celcuity Inc. is to improve the outcomes of cancer patients by developing extended treatment options through their novel therapeutics. They strive to provide treatments that are more effective and personalized, catering to the specific biological characteristics of individual tumors.
What is the role of the board of directors at Celcuity?
The board of directors at Celcuity Inc. is responsible for overseeing the company’s strategic direction and governance. They provide guidance on corporate policies, ensure compliance with regulations, and support the executive management team in achieving the company's goals related to drug development and commercialization.
What is the stock symbol for Celcuity Inc.?
The stock symbol for Celcuity Inc. is CELC. It is listed on the Nasdaq stock exchange, where investors can buy and sell shares of the company as it works towards advancing its cancer therapies.
What is the target patient population for Celcuity's drugs?
The target patient population for Celcuity's drugs includes individuals diagnosed with cancer, particularly those with specific genetic mutations or biomarkers that their therapies are designed to address. Personalized medicine is a key focus, allowing treatments to be tailored to the unique characteristics of each patient’s cancer.
What types of cancers is Celcuity focusing on?
Celcuity is currently focusing on developing therapies for several types of cancers, including breast cancer, colorectal cancer, and certain types of hematologic malignancies. The company's targeted approach aims to create treatments that can tackle specific genetic mutations and cellular characteristics of tumors.
When was Celcuity Inc. founded?
Celcuity Inc. was founded in 2011. The company's establishment was driven by the desire to enhance cancer treatment through a better understanding of cellular signaling pathways and the development of drug therapies tailored to individual patients' needs.
Where is Celcuity Inc. headquartered?
Celcuity Inc. is headquartered in Minneapolis, Minnesota. This strategic location allows the company to collaborate with regional medical institutions and research organizations, enhancing its capabilities in drug development.
Who are the key executives at Celcuity?
Celcuity Inc. is led by a team of experienced executives in the pharmaceutical and biotechnology industries. Key figures often include the CEO, CFO, and other C-level management whose expertise guides the company through research, clinical development, and business strategy.
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 11.12
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 4:00 pm EDT on April 22nd, 2025
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 420.77M
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 37.84M shares outstanding.